Caribou Biosciences (CRBU) Other Non-Current Assets (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Other Non-Current Assets data on file, last reported at $2.1 million in Q1 2026.

• Quarterly Other Non-Current Assets fell 57.62% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 57.62% YoY) and the FY2025 annual result came in at $2.2 million, down 60.15% from the prior year.
• Other Non-Current Assets declined to $2.1 million in Q1 2026 per CRBU's latest filing, from $2.2 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $5.5 million in Q4 2024 and bottomed at $1.3 million in Q2 2022.
• The 5-year median for Other Non-Current Assets is $1.6 million (2024), against an average of $2.5 million.
• The widest annual swing landed in 2022, when Other Non-Current Assets sank 61.63%; it then surged 248.11% in 2024.
• Tracing CRBU's Other Non-Current Assets over 5 years: stood at $1.5 million in 2022, then increased by 3.12% to $1.6 million in 2023, then surged by 248.11% to $5.5 million in 2024, then plunged by 60.15% to $2.2 million in 2025, then slipped by 2.86% to $2.1 million in 2026.
• Per Business Quant, the three latest CRBU Other Non-Current Assets figures stand at $2.1 million (Q1 2026), $2.2 million (Q4 2025), and $3.8 million (Q3 2025).

Peer Comparison